We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+34.38%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$559M
AUM Growth
+$154M
Cap. Flow
+$5.35M
Cap. Flow %
0.96%
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
–
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
+$22.3M
2
SDS icon
ProShares UltraShort S&P500
SDS
+$17.6M
3
CLDX icon
Celldex Therapeutics
CLDX
+$14.4M

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$47.3M
2
EPI icon
WisdomTree India Earnings Fund ETF
EPI
+$891K
3
VVUS
Vivus Inc
VVUS
+$792K

Sector Composition

Rank Sector Weight
1 Healthcare 87.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$416M 74.32%
19,183,713
-2,326,000
-11% -$47.3M
ALKS icon
2
Alkermes
ALKS
$8.82B
$60.3M 10.78%
1,030,639
– –
SPXU icon
3
ProShares UltraPro Short S&P 500
SPXU
$436M
$21.1M 3.77%
+3,075
New +$22.3M
SDS icon
4
ProShares UltraShort S&P500
SDS
$406M
$16.9M 3.03%
+12,600
New +$17.6M
EPI icon
5
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$15.2M 2.72%
630,000
-40,000
-6% -$891K
INDA icon
6
iShares MSCI India ETF
INDA
$6.71B
$15.1M 2.7%
480,000
– –
CLDX icon
7
Celldex Therapeutics
CLDX
$2.77B
$15M 2.68%
+276,393
New +$14.4M
VVUS
8
DELISTED
Vivus Inc
VVUS
– –
-68,850
Closed -$792K

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q1 2017 Portfolio in Review

As of Q1 2017, Meditor Group held 8 positions worth $559M, up 38% from $405M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group's Q1 2017 filing shows 3 new, 2 reduced and 1 closed positions. Its largest new stake was ProShares UltraPro Short S&P 500: 3,075 shares worth $21.1M. The largest sale was Exelixis, an estimated $47.3M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 93% a quarter earlier.

  • Meditor Group's largest Q1 2017 buy was ProShares UltraPro Short S&P 500: 3,075 shares worth $21.1M.
  • Meditor Group's biggest Q1 2017 reduction was Exelixis, cutting an estimated $47.3M.
  • Meditor Group fully exited Vivus Inc in Q1 2017, selling an estimated $792K.
  • Meditor Group's ten largest holdings make up 100% of its $559M portfolio in Q1 2017.
  • Meditor Group opened 3 new positions and closed 1 in Q1 2017.
  • Meditor Group's portfolio value rose 38% quarter-over-quarter to $559M.

Based on Meditor Group's 13F filing for Q1 2017, filed 24 Apr 2017.